Harbert Fund Advisors, Inc.
- SEC CIK
- 0001616659
- Latest filing
- Aug 17, 2026
FENC holding history
Fennec Pharmaceuticals Inc. in every 13F filed by Harbert Fund Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FENC overviewAll 13F holders of FENCFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −177,815−100.0% | Sold out | Holders |
| Q3 2025 | 177,815 | $1.66M | 10.9% | −109,799−38.2% | Reduced | Holders |
| Q2 2025 | 287,614 | $2.39M | 7.2% | −179,255−38.4% | Reduced | Holders |
| Q1 2025 | 466,869 | $2.84M | 3.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 466,869 | $2.95M | 2.6% | 00.0% | Unchanged | Holders |
| Q3 2024 | 466,869 | $2.33M | 1.9% | 00.0% | Unchanged | Holders |
| Q2 2024 | 466,869 | $2.85M | 2.3% | 00.0% | Unchanged | Holders |
| Q1 2024 | 466,869 | $5.19M | 3.6% | 00.0% | Unchanged | Holders |
| Q4 2023 | 466,869 | $5.24M | 3.6% | 00.0% | Unchanged | Holders |
| Q3 2023 | 466,869 | $3.51M | 2.5% | 00.0% | Unchanged | Holders |
| Q2 2023 | 466,869 | $4.12M | 2.6% | 00.0% | Unchanged | Holders |
| Q1 2023 | 466,869 | $3.88M | 2.8% | +149,920+47.3% | Added | Holders |
| Q4 2022 | 316,949 | $3.04M | 2.6% | +127,199+67.0% | Added | Holders |
| Q3 2022 | 189,750 | $1.54M | 1.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 189,750 | $1.06M | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2022 | 189,750 | $1.06M | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2021 | 189,750 | $835.0K | 0.4% | +15,000+8.6% | Added | Holders |
| Q3 2021 | 174,750 | $1.65M | 0.9% | +53,899+44.6% | Added | Holders |
| Q2 2021 | 120,851 | $881.0K | 0.5% | +120,851 | New | Holders |